Sign Up Today and Learn More About FogPharma Stock
Invest in or calculate the value of your shares in FogPharma or other pre-IPO companies through EquityZen's platform.
FogPharma Stock (FOGP)
FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.
About FogPharma Stock
Founded
2015
Headquarters
Cambridge, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
FogPharma Press Mentions
Stay in the know about the latest news on FogPharma
Parabilis Medicines Expands Executive Leadership Team
biospace • Apr 14, 2026
Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors
biospace • Mar 11, 2026
On Its 15th Anniversary, Foresite Capital Looks Ahead
genengnews • Feb 19, 2026
The biggest biotech funding rounds in January 2026
labiotech • Feb 05, 2026
China’s Corxel Nabs $287M Series D1 to Bankroll GLP-1 Pill
biospace • Jan 23, 2026
FogPharma Management
Leadership team at FogPharma
Founder, CEO, CSO
Greg Verdine
Co-founder & COO
Weiqing Zhou
Join now and verify your accreditation status to gain access to:
- FogPharma Current Valuation
- FogPharma Stock Price
- FogPharma Management
- Available deals in FogPharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- FogPharma Cap Table and Funding History by Share Class and Liquidity Preferences
- FogPharma Revenue and Financials
- FogPharma Highlights
- FogPharma Business Model
- FogPharma Risk Factors
- FogPharma Research Report from SACRA Research
Trading FogPharma Stock
How to invest in FogPharma stock?
Accredited investors can buy pre-IPO stock in companies like FogPharma through EquityZen funds. These investments are made available by existing FogPharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell FogPharma stock?
Shareholders can sell their FogPharma stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
